REGENXBIO Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$1.26 | -$1.26 | -$1.26 |
| Q2 2024 | 2 | -$1.29 | -$1.29 | -$1.29 |
| Q3 2024 | 6 | -$1.24 | -$1.05 | -$1.12 |
| Q4 2024 | 2 | -$1.03 | -$1.03 | -$1.03 |
| Q1 2025 | 5 | -$1.16 | -$1.16 | -$1.16 |
| Q2 2025 | 5 | $0.51 | $0.51 | $0.51 |
| Q3 2025 | 5 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2025 | 5 | -$0.08 | -$0.08 | -$0.08 |
REGENXBIO Inc. Earnings Date And Information
REGENXBIO Inc. last posted its earnings results on Thursday, August 1st, 2024. The company reported $-1.05 earnings per share for the quarter, topping analysts' consensus estimates of $-1.29 by $0.24. The company had revenue of 22.30 M for the quarter and had revenue of 90.24 M for the year. REGENXBIO Inc. has generated $-6 earnings per share over the last year ($-6.02 diluted earnings per share) and currently has a price-to-earnings ratio of -1.87. REGENXBIO Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based on prior year's report dates.
REGENXBIO Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/01/2024 | Q2 2024 | -$1.29 | -$1.05 | 0.24 | $22.97 M | $22.30 M |
| 05/08/2024 | Q1 2024 | -$1.28 | -$1.38 | -0.1 | $15.62 M | |
| 02/27/2024 | Q4 2023 | -$1.27 | -$1.43 | -0.16 | $22.21 M | |
| 11/08/2023 | Q3 2023 | -$1.44 | -$1.41 | 0.03 | $26.14 M | $28.91 M |
| 08/02/2023 | Q2 2023 | -$1.26 | -$1.66 | -0.4 | $34.50 M | $19.98 M |
| 05/03/2023 | Q1 2023 | -$1.52 | -$1.61 | -0.09 | $19.14 M | |
| 02/28/2023 | Q4 2022 | -$1.48 | -$1.38 | 0.1 | $31.35 M | |
| 11/03/2022 | Q3 2022 | -$1.55 | -$1.85 | -0.3 | $30.81 M | $26.51 M |
| 08/03/2022 | Q2 2022 | -$1.44 | -$1.58 | -0.14 | $28.31 M | $32.65 M |
| 05/04/2022 | Q1 2022 | -$1.29 | -$1.79 | -0.5 | $22.22 M | |
| 03/01/2022 | Q4 2021 | $4.71 | $6.87 | 2.16 | $398.66 M | |
| 11/02/2021 | Q3 2021 | -$0.87 | -$1.37 | -0.5 | $33.17 M | $30.77 M |
| 08/09/2021 | Q2 2021 | -$1.08 | -$1.36 | -0.28 | $21.17 M | $22.04 M |
| 05/05/2021 | Q1 2021 | -$1.13 | -$1.20 | -0.07 | $18.88 M | |
| 03/01/2021 | Q4 2020 | $1.11 | -$1.24 | -2.35 | $21.45 M | |
| 11/04/2020 | Q3 2020 | -$0.89 | $0.24 | 1.13 | $21.45 M | $98.91 M |
| 08/06/2020 | Q2 2020 | -$0.89 | -$0.91 | -0.02 | $20.46 M | $16.57 M |
| 05/07/2020 | Q1 2020 | -$0.87 | -$1.08 | -0.21 | $17.64 M | |
| 02/26/2020 | Q4 2019 | -$0.40 | -$0.72 | -0.32 | $11.77 M | |
| 11/05/2019 | Q3 2019 | -$0.91 | -$0.94 | -0.03 | $7.46 M | $14.70 M |
REGENXBIO Inc. Earnings: Frequently Asked Questions
-
When is REGENXBIO Inc.'s earnings date?
REGENXBIO Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates.
-
Did REGENXBIO Inc. beat their earnings estimates last quarter?
In the previous quarter, REGENXBIO Inc. (:RGNX) reported $-1.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.29 by $0.24.
-
How can I listen to REGENXBIO Inc.'s earnings conference call?
The conference call for REGENXBIO Inc.'s latest earnings report can be listened to online.
-
How can I read REGENXBIO Inc.'s conference call transcript?
The conference call transcript for REGENXBIO Inc.'s latest earnings report can be read online.
-
How much revenue does REGENXBIO Inc. generate each year?
REGENXBIO Inc. (:RGNX) has a recorded annual revenue of $90.24 M.
-
How much profit does REGENXBIO Inc. generate each year?
REGENXBIO Inc. (:RGNX) has a recorded net income of $90.24 M. REGENXBIO Inc. has generated $-6.02 earnings per share over the last four quarters.
-
What is REGENXBIO Inc.'s price-to-earnings ratio?
REGENXBIO Inc. (:RGNX) has a price-to-earnings ratio of -1.87 and price/earnings-to-growth ratio is -0.18.
